Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > New Insider Buys

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Jan 24, 2021 8:51pm

172 Views

Post# 32372522

RE:RE:RE:RE:RE:New Insider Buys

Unfortunately you don't get the warrants when you buy tomorrow ;) ... it's really free shares!!!!

-LT

realitycheck4u wrote: Palinc,

So you are upset to have not been able to buy in - at a much higher price than you can now - and yet you're complaining? The stock is way below it. So, buy more Monday - or do not complain.

palinc2000 wrote: This just proves that the deal was under priced,,,,I wiish bI had been offered to participate in thev Offering